Authors:
Wittig, B
Marten, A
Dorbic, T
Weineck, S
Min, H
Niemitz, S
Trojaneck, B
Flieger, D
Kruopis, S
Albers, A
Loffel, J
Neubauer, A
Albers, P
Muller, S
Sauerbruch, T
Bieber, T
Huhn, D
Schmidt-Wolf, IGH
Citation: B. Wittig et al., Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial, HUM GENE TH, 12(3), 2001, pp. 267-278
Authors:
Kingreen, D
Beyer, J
Kleiner, S
Reif, S
Huhn, D
Siegert, W
Citation: D. Kingreen et al., ICE - an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma, EUR J HAEMA, 66, 2001, pp. 46-50
Authors:
Serke, S
Schwaner, I
Yordanova, M
Szczepek, A
Huhn, D
Citation: S. Serke et al., Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after rituxan therapy and transfectant cellanalyses, CYTOMETRY, 46(2), 2001, pp. 98-104
Authors:
Marten, A
Schottker, B
Ziske, C
Weineck, S
Buttgereit, P
Huhn, D
Sauerbruch, T
Schmidt-Wolf, IGH
Citation: A. Marten et al., Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein, J IMMUNOTH, 23(4), 2000, pp. 464-472
Authors:
Lefterova, P
Marten, A
Buttgereit, P
Weineck, S
Scheffold, C
Huhn, D
Schmidt-Wolf, IGH
Citation: P. Lefterova et al., Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity, J IMMUNOTH, 23(3), 2000, pp. 304-310
Authors:
Trojaneck, B
Niemitz, S
Micka, B
Lefterova, P
Blasczyk, R
Scheffold, C
Huhn, D
Schmidt-Wolf, IGH
Citation: B. Trojaneck et al., Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures, CANC BIO R, 15(2), 2000, pp. 169-174
Authors:
Hildebrandt, M
Rick, O
Salama, A
Siegert, W
Huhn, D
Beyer, J
Citation: M. Hildebrandt et al., Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: Impact on clinical outcome, CLIN CANC R, 6(12), 2000, pp. 4641-4646
Authors:
Zoll, B
Lefterova, P
Ebert, O
Huhn, D
Von Ruecker, A
Schmidt-Wolf, IGH
Citation: B. Zoll et al., Modulation of cell surface markers on NK-like T lymphocytes by using IL-2,IL-7 or IL-12 in vitro stimulation, CYTOKINE, 12(9), 2000, pp. 1385-1390
Authors:
Oettle, H
Arnold, D
Esser, M
Huhn, D
Riess, H
Citation: H. Oettle et al., Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma, ANTI-CANC D, 11(8), 2000, pp. 635-638
Authors:
Schneider, U
Ruhnke, M
Delecluse, HJ
Stein, H
Huhn, D
Citation: U. Schneider et al., Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet, ANN HEMATOL, 79(4), 2000, pp. 214-216
Authors:
Rick, O
Beyer, J
Kingreen, D
Kuhl, JS
Zingsem, J
Huhn, D
Siegert, W
Schwella, N
Citation: O. Rick et al., Successful autologous bone marrow rescue in patients who failed peripheralblood stem cell mobilization, ANN HEMATOL, 79(12), 2000, pp. 681-686
Authors:
Buttgereit, P
Weineck, S
Ropke, G
Marten, A
Brand, K
Heinicke, T
Caselmann, WH
Huhn, D
Schmidt-Wolf, IGH
Citation: P. Buttgereit et al., Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection, CANC GENE T, 7(8), 2000, pp. 1145-1155
Authors:
Ropke, G
Ebert, O
Marten, A
Lefterova, P
Micka, B
Buttgereit, P
Niemitz, S
Trojaneck, E
Schmidt-Wolf, G
von Rucker, A
Huhn, D
Wittig, B
Schmidt-Wolf, IGH
Citation: G. Ropke et al., Increase in proliferation rate and normalization of TNF-alpha secretion byblockage of gene transfer-induced apoptosis in lymphocytes using low-dose cyclosporine A, CANC GENE T, 7(11), 2000, pp. 1411-1413
Authors:
Oettle, H
Arning, M
Pelzer, U
Arnold, D
Stroszczynski, C
Langrehr, J
Reitzig, P
Kindler, M
Herrenberger, J
Musch, R
Korsten, FW
Huhn, D
Riess, H
Citation: H. Oettle et al., A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer, ANN ONCOL, 11(10), 2000, pp. 1267-1272
Authors:
Lefterova, P
Schakowski, F
Buttgereit, P
Scheffold, C
Huhn, D
Schmidt-Wolf, IGH
Citation: P. Lefterova et al., Expansion of CD3(+)CD56(+) cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy, HAEMATOLOG, 85(10), 2000, pp. 1108-1109
Authors:
Herold, M
Strohl, J
Assmann, M
Eschenburg, H
Franke, A
Freund, M
von Grunhagen, U
Hahnfeld, S
Hoffmann, FA
Huhn, D
Klinkenstein, C
Knauf, W
Pasold, R
Hurtz, HJ
Steglich, J
Wolf, H
Citation: M. Herold et al., Acute toxicity of mitoxantrone, chlorambucil and prednisolone (MCP) versusMCP plus rituximab in low-grade non-Hodgkin's lymphoma - Interim results of a phase III trial, ONKOLOGIE, 23(2), 2000, pp. 164-166
Authors:
Serke, S
van Lessen, A
Hummel, M
Szczepek, A
Huhn, D
Stein, H
Citation: S. Serke et al., Circulating CD4+T lymphocytes with intracellular but no surface CD3 antigen in live of seven patients consecutively diagnosed with angioimmunoblasticT-cell lymphoma, CYTOMETRY, 42(3), 2000, pp. 180-187
Authors:
Kreuzer, KA
Lass, U
Nagel, S
Ellerbrok, H
Pauli, G
Pawlaczyk-Peter, B
Siegert, W
Huhn, D
Schmidt, CA
Citation: Ka. Kreuzer et al., Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients, INT J CANC, 86(5), 2000, pp. 741-746
Authors:
Scheffold, C
Schottker, B
Lefterova, P
Csipai, M
Glasmacher, A
Huhn, D
Neubauer, A
Schmidt-Wolf, IGH
Citation: C. Scheffold et al., Increased sensitivity of myeloid leukemia cell lines: Potential of lovastatin as bone-marrow-purging agent, ACT HAEMAT, 104(2-3), 2000, pp. 72-79